2001
Sexual Orientation and HIV Infection Prevalence among Young Latino Injection Drug Users in Harlem
Diaz T, Vlahov D, Greenberg B, Cuevas Y, Garfein R. Sexual Orientation and HIV Infection Prevalence among Young Latino Injection Drug Users in Harlem. Journal Of Women's Health 2001, 10: 371-380. PMID: 11445028, DOI: 10.1089/152460901750269698.Peer-Reviewed Original ResearchConceptsInjection drug usersHIV infection prevalenceHIV infectionUnprotected sexHomosexual menDrug usersOlder injection drug usersHeterosexual menInfection prevalenceHIV infection ratesCohort studyHepatitis BAntibody testingWhole cohortSexual transmissionHigh prevalenceHigh riskOlder menHeterosexual womenLarger sample sizeDrug useInfection rateMultivariate analysisNew York CityYoung women
2000
Gender differences in the initiation of injection drug use among young adults
Doherty M, Garfein R, Monterroso E, Latkin C, Vlahov D. Gender differences in the initiation of injection drug use among young adults. Journal Of Urban Health 2000, 77: 396-414. PMID: 10976613, PMCID: PMC3456045, DOI: 10.1007/bf02386749.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusInjection drug useHIV risk profilesDrug useRisk behaviorsRisk profileLow HIV prevalenceInjection drug usersMale sex partnersCommunity-based recruitmentPercentage of womenMale IDUsHIV prevalenceImmunodeficiency virusRisky injectionMost womenGender differencesDrug usersSex partnersInjection initiationYoung womenPatterns of initiationNumber of personsYoung adultsWomen
1991
Prevalence of Antibody to HIV-1 Among Entrants to US Correctional Facilities
Vlahov D, Brewer T, Castro K, Narkunas J, Salive M, Ullrich J, Muñoz A. Prevalence of Antibody to HIV-1 Among Entrants to US Correctional Facilities. JAMA 1991, 265: 1129-1132. PMID: 1995998, DOI: 10.1001/jama.1991.03460090077036.Peer-Reviewed Original ResearchConceptsPrevalence of antibodiesHuman immunodeficiency virus type 1Immunodeficiency virus type 1HIV-1 prevalenceHIV-1 seroprevalenceAge 25 yearsVirus type 1US correctional facilitiesConsecutive malesHIV-1Older womenOlder menPrevention programsType 1Young womenPrevalenceWomenCorrectional systemYoung menMenSeroprevalenceAntibodiesProgram planningCorrectional facilities